The aim of Sydney Catalyst is to
improve the outcomes of those affected by cancer or at risk of
developing it, through discovery, new knowledge and the development
and implementation of more effective cancer treatments, supportive
care and preventative strategies.
To achieve this, we have established a translational cancer
research program built on a broad cross-disciplinary team with
skills in many areas including genomics, cancer biology/molecular
oncology and molecular profiling, biobanking, bioinformatics, drug
development, biostatistics and clinical epidemiology, as well as
strong communication, education and operational strategies to
ensure these diverse teams can work collaboratively and
effectively.
Subsequent to our initial Translational Cancer Research Centre
grant awarded by the Cancer Institute NSW in 2011, Sydney Catalyst a
second five year grant in June 2016.
A copy of our Strategic Planning document can be found here.
Major Goals of Sydney Catalyst
- Goal 1 - Develop and implement a
comprehensive research program across the translational continuum -
T1, T2 and T3.
KEY OBJECTIVES
- Goal 2 - Facilitate improved
professional development, communication, and collaboration across
the consortium.
KEY OBJECTIVES
- Goal 3 - Build capacity in research,
improve competitive advantage in securing other funds
KEY OBJECTIVES
- Goal 4 -Challenge the traditional,
administrative and institutional barriers between clinicians and
researchers to support a culture of embedding research and evidence
in cancer healthcare